Uncovering disease and cell-type-specific constraints on therapeutic delivery using a human CNS tissue discovery platform Post author: Post published: November 21, 2026 Post category: Continue ReadingUncovering disease and cell-type-specific constraints on therapeutic delivery using a human CNS tissue discovery platform
Mapping Human Retinal Niches to Improve Stem-Cell Therapy for Geographic Atrophy Post author: Post published: November 21, 2026 Post category: Continue ReadingMapping Human Retinal Niches to Improve Stem-Cell Therapy for Geographic Atrophy
Leveraging lessons from normal development to overcome barriers to efficient transplantation of stem cell derived cortical neurons. Post author: Post published: November 21, 2026 Post category: Continue ReadingLeveraging lessons from normal development to overcome barriers to efficient transplantation of stem cell derived cortical neurons.
Hypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes Post author: Post published: November 21, 2026 Post category: Continue ReadingHypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes
Regenerating the Acutely Infarcted Heart with iPSC-Ventricular Cardiomyocytes. Post author: Post published: November 21, 2026 Post category: Continue ReadingRegenerating the Acutely Infarcted Heart with iPSC-Ventricular Cardiomyocytes.
Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy for Multiple Sclerosis Post author: Post published: November 21, 2026 Post category: Continue ReadingStem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy for Multiple Sclerosis
A First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events Post author: Post published: November 21, 2026 Post category: Continue ReadingA First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events
Gene Therapy for Alpha-1 Anti-Trypsin Deficiency Post author: Post published: November 21, 2026 Post category: Continue ReadingGene Therapy for Alpha-1 Anti-Trypsin Deficiency
Late-stage development of AS-241, an UNC13A Targeting Antisense Oligonucleotide treatment for Amyotrophic Lateral Sclerosis, for IND-enabling studies Post author: Post published: November 21, 2026 Post category: Continue ReadingLate-stage development of AS-241, an UNC13A Targeting Antisense Oligonucleotide treatment for Amyotrophic Lateral Sclerosis, for IND-enabling studies
Advancement of a myotropic, liver-detargeting therapy for LGMD2i/R9 Post author: Post published: November 21, 2026 Post category: Continue ReadingAdvancement of a myotropic, liver-detargeting therapy for LGMD2i/R9